|
注册号: Registration number: |
ChiCTR-RDC-17012834 |
|
最近更新日期: Date of Last Refreshed on: |
2017-09-29 11:56:23 |
|
注册时间: Date of Registration: |
2017-09-29 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
磁共振T2mapping和IDEAL成像技术对腰椎间盘退变的定量评价 |
|
Public title: |
Quantitative assessment of intervertebral disc degeneration using T2 mapping and IDEAL |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
磁共振T2mapping和IDEAL成像技术对腰椎间盘退变的定量评价 |
|
Scientific title: |
Quantitative assessment of intervertebral disc degeneration using T2 mapping and IDEAL |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
陈晓飞 |
研究负责人: |
周晟 |
|
Applicant: |
Xiao-fei Chen |
Study leader: |
Sheng Zhou |
|
申请注册联系人电话: Applicant telephone: |
+86 13919044908 |
研究负责人电话:
Study leader's |
+86 15002591656 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
cxf750915@sina.com |
研究负责人电子邮件: Study leader's E-mail: |
lzzs@sina.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
甘肃省兰州市七里河区瓜州路418号 |
研究负责人通讯地址: |
甘肃省兰州市七里河区瓜州路418号 |
|
Applicant address: |
418 Guazhou Road, Qilihe District, Lanzhou, China |
Study leader's address: |
418 Guazhou Road, Qilihe District, Lanzhou, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
甘肃省中医院 |
||
|
Applicant's institution: |
Gansu provincial hospital of TCM |
||
|
研究负责人所在单位: |
甘肃省中医院 |
||
|
Affiliation of the Leader: |
Gansu provincial hospital of TCM |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2017-055-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
甘肃省中医院伦理委员会 |
||
|
Name of the ethic committee: |
The ethics committee of Gansu provincial hospital of TCM |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2017-09-14 00:00:00 | ||
|
伦理委员会联系人: |
|
||
|
Contact Name of the ethic committee: |
|
||
|
伦理委员会联系地址: |
|
||
|
Contact Address of the ethic committee: |
|
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
甘肃省中医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Gansu provincial hospital of TCM |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
甘肃省兰州市七里河区瓜州路418号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
418 Guazhou Road, Qilihe District,Lanzhou, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
甘肃省中医院、甘肃省科技厅 |
||||||||||||||||||||||
|
Source(s) of funding: |
Funding by Gansu provincial hospital of TCM and Gansu provincial Sci. and Tech. Department |
||||||||||||||||||||||
|
研究疾病: |
椎间盘退变 |
||||||||||||||||||||||
|
Target disease: |
intervertebral disc degeneration |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
病因学/相关因素研究 |
||||||||||||||||||||||
|
Study type: |
Cause/Relative factors study |
||||||||||||||||||||||
|
研究所处阶段: |
诊断试验新技术临床试验 | ||||||||||||||||||||||
|
Study phase: |
Diagnostic New Technique Clincal Study |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
基于磁共振QMRI技术,在3.0T磁共振成像系统平台上,采集下腰痛患者的T2mapping成像、IDEAL加权成像数据。分析IVDD的T2值、FSF、WSF与Pfirrmann分级及下腰痛临床评分的相关性。对比研究磁共振T2mapping成像、IDEAL成像的对IVDD定量的优势,探讨QMRI对IVDD早期定量诊断的应用价值。 |
||||||||||||||||||||||
|
Objectives of Study: |
Based on QMRI, T2mapping imaging and IDEAL weighted imaging data of patients with lower back pain were acquired on the 3.0T MRI. T2 value of IVDD, FSF, WSF and Pfirrmann grading and lower back pain was analyzed. To compare the quantitative advantages of T2mapping imaging and IDEAL imaging to IVDD. Explore the application value of QMRI in early quantitative diagnosis of IVDD. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
妊娠,哺乳期妇女;重患者或存在心、肝、肾功能衰竭;精神障碍、肢体残疾、智力障碍;不愿受试者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Pregnancy, lactating women; Patients with heart, liver, renal multiple system organ failure; Mental disorders, physical disability, mental retardation; Claustrophobia;Unwilling subjects. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2017-10-01 00:00:00至 To 2019-09-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2017-10-01 00:00:00 至 To 2019-09-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
由三名诊断医师根据Pfirrmann分级标准,对椎间盘进行分级分组,不做随机处理。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
According to the classification standard of Pfirrmann, the three diagnostic doctors classified the intervertebral discs and did not do random processing. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
试验完成后6月内公开 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Within six months after the trial complete |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |